drugset
drugset / Trial / NCT00420953

Relative Bioavailability of PM101 IV and Cordarone IV

NCT00420953 ↗

Phase 1 Completed Prism Pharmaceuticals
RandomizedCrossoverDouble-blindTreatment

Summary

Determine the relative bioavailability of PM101 I.V. and Cordarone I.V.

Timeline

Start
2006-12-18
Primary completion
2007-04-23
Completion
2007-04-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule — Intravenous

Indications

No indication recorded.